FDA Approves First Blood Test for Alzheimer’s Disease
The presence of amyloid plaques and neurofibrillary tangles in the brain has long been considered the biological sign or biomarkers of Alzheimer’s disease. Plaques form as a result of amyloid-beta protein clumping and depositing outside of the neurons in the [View More]